Exagen Inc —— 现金流量表 (NASDAQ:XGN)

Financials

经营活动产生的现金 -14.08 M-20.27 M-32.14 M-14.46 M-13.28 M-13.63 M -13.63 M 投资活动产生的现金 -455 K-2.42 M-4.32 M-804 K-515 K-626 K -626 K 融资活动产生的现金 -97 K64.68 M-489 K-10.63 M-663 K24.43 M 24.43 M 自由现金流 -14.54 M-22.64 M-36.46 M-15.29 M-13.79 M-14.27 M -14.27 M

新闻

KeyBanc因定价压力下调Exagen目标价

KeyBanc cuts Exagen stock price target on pricing headwinds

Exagen Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-03-11

Canaccord因利润率前景将Exagen目标价下调至10美元

Exagen stock price target lowered to $10 by Canaccord on margin outlook

BTIG因营收前景下调Exagen目标价至9美元

BTIG cuts Exagen stock price target to $9 on lower revenue outlook

William Blair维持Exagen股票跑赢大盘评级

Exagen stock maintains Outperform rating at William Blair

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates

ExagenQ1每股收益及营收逊于预期

Exagen earnings missed by $0.01, revenue fell short of estimates